KP

Kavita Priyank Rajmane

Active Director Director DIN 09127560
DIN 09127560 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Kavita Priyank Rajmane

Data last updated:

Kavita Priyank Rajmane is a Director at Medisam Biomedical Systems Private Limited (since 2021). The company operates in Pharma. Medisam Biomedical Systems Private Limited reported revenue of ₹5.05 Cr (FY 2025).

DIN 09127560
Primary Designation Director
Industry Pharma
First Appointment 27 Mar 2021
Oldest Company Age 7 yrs
Largest company Medisam Biomedical Systems Private Limited · ₹5.05 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Mar 20212018₹5.05 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Medisam Biomedical Systems Private Limited
Premium access

Shareholding and investment profile for Kavita Priyank Rajmane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita Priyank Rajmane

Kavita Priyank Rajmane currently holds 1 directorship: Medisam Biomedical Systems Private Limited (Director, since 27 Mar 2021, revenue ₹5.05 Cr (FY 2025)).

Kavita Priyank Rajmane was first appointed on 27 Mar 2021 as Director at Medisam Biomedical Systems Private Limited.

The current boards of Kavita Priyank Rajmane's companies include Kiran Tanaji Jadhav (Medisam Biomedical Systems Private Limited), Priti Kiran Jadhav (Medisam Biomedical Systems Private Limited), Priyank Ramchandra Rajmane (Medisam Biomedical Systems Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available